Same but different? A thematic analysis on adalimumab biosimilar switching among patients with juvenile idiopathic arthritis

BACKGROUND: Biologic medications have dramatically enhanced the treatment of many chronic paediatric inflammatory conditions. Their high cost is a factor that prohibits their broader use. Cheaper generic versions, or biosimilars, are increasingly being used. Healthcare services are switching some pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Renton, William D., Leveret, Helen, Guly, Catherine, Smee, Heather, Leveret, Jamie, Ramanan, Athimalaipet V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778384/
https://www.ncbi.nlm.nih.gov/pubmed/31585539
http://dx.doi.org/10.1186/s12969-019-0366-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778384/
https://www.ncbi.nlm.nih.gov/pubmed/31585539
http://dx.doi.org/10.1186/s12969-019-0366-x

Ejemplares similares